Home > News > DNA-Based Nanoengine for On-Demand Drug Release
August 15th, 2005
DNA-Based Nanoengine for On-Demand Drug Release
Abstract:
Nucleic acid aptamers are small pieces of DNA or RNA designed not to convey genetic information but to bind tightly to specific proteins and other biological molecules. Numerous investigators have used aptamers as replacements for antibodies in various therapeutic and diagnostic applications, and now a team at McMaster University has found a third use for these versatile molecules – as the heart of a DNA-protein nanoengine that can be programmed to release therapeutically useful molecules in response to a programmed molecular signal.
Source:
nano.cancer.gov
Bookmark:
| Related Links |
| Related News Press |
Molecular Machines
First electric nanomotor made from DNA material: Synthetic rotary motors at the nanoscale perform mechanical work July 22nd, 2022
Nanotech scientists create world's smallest origami bird March 17th, 2021
Giant nanomachine aids the immune system: Theoretical chemistry August 28th, 2020
Nanomedicine
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Next-generation drug delivery innovation! DGIST develops precision therapeutics using exosomes April 25th, 2025
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Announcements
Enhancing power factor of p- and n-type single-walled carbon nanotubes April 25th, 2025
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Ultrafast plasmon-enhanced magnetic bit switching at the nanoscale April 25th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||